Profile - To The Moon

BlueHi5

Posts · 154Posts · 154
Following · 0Following · 0
Followers · 0Followers · 0

- BlueHi5BlueHi5
  ·2021-09-23
  Commenting
  As SoFi stock surges, one analyst sees at least 50% more upside
  Jefferies initiates coverage of SoFi shares with a bullish rating SoFi Technologies Inc.'s strong pr
  As SoFi stock surges, one analyst sees at least 50% more upside
  5.28K 1
  3
  Share
  Report
- BlueHi5BlueHi5
  ·2021-09-22
  Post
  Sorry, this post has been deleted
  5.23K 1
  5
  Share
  Report
- BlueHi5BlueHi5
  ·2021-09-21
  Comment
  UK's Johnson discussed taxation with Amazon's Bezos
  LONDON, Sept 21 (Reuters) - British Prime Minister Boris Johnson discussed the issue of taxation whe
  UK's Johnson discussed taxation with Amazon's Bezos
  5.35K 1
  5
  Share
  Report
- BlueHi5BlueHi5
  ·2021-09-21
  Comment
  Sorry, this post has been deleted
  3.88K Comment
  1
  Share
  Report
- BlueHi5BlueHi5
  ·2021-09-20
  Comment
  Sorry, this post has been deleted
  3.60K Comment
  4
  Share
  Report
- BlueHi5BlueHi5
  ·2021-09-19
  Comment
  Sorry, this post has been deleted
  4.52K 1
  5
  Share
  Report
- BlueHi5BlueHi5
  ·2021-09-18
  Comment
  Sorry, this post has been deleted
  5.48K 2
  7
  Share
  Report
- BlueHi5BlueHi5
  ·2021-09-16
  Comment
  3 COVID Stocks That Might Double Soon
  Here are three healthcare stocks as nominees for a quick double in 2021.
  3 COVID Stocks That Might Double Soon
  4.82K 1
  6
  Share
  Report
- BlueHi5BlueHi5
  ·2021-09-15
  Comment
  Cathie Wood Continues To Trim Tesla Stake, Selling Another $66M Worth Of Shares
  Cathie Wood-led Ark Invest on Tuesday further lowered some of its exposure in Tesla Inc (Get Free Al
  Cathie Wood Continues To Trim Tesla Stake, Selling Another $66M Worth Of Shares
  4.78K 1
  2
  Share
  Report
- BlueHi5BlueHi5
  ·2021-09-14
  Liked
  Sorry, this post has been deleted
  4.83K 1
  2
  Share
  Report
No followers yet

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3583641915640836","uuid":"3583641915640836","gmtCreate":1620548434481,"gmtModify":1624544178240,"name":"BlueHi5","pinyin":"bluehi5","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":11,"headSize":326,"tweetSize":154,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.29%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":863120435,"gmtCreate":1632365653427,"gmtModify":1676530764380,"author":{"id":"3583641915640836","authorId":"3583641915640836","name":"BlueHi5","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583641915640836","idStr":"3583641915640836"},"themes":[],"title":"","htmlText":"Commenting&nbsp;","listText":"Commenting&nbsp;","text":"Commenting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/863120435","repostId":"2169657704","repostType":4,"repost":{"id":"2169657704","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1632364080,"share":"https://ttm.financial/m/news/2169657704?lang=en_US&edition=fundamental","pubTime":"2021-09-23 10:28","market":"us","language":"en","title":"As SoFi stock surges, one analyst sees at least 50% more upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2169657704","media":"Dow Jones","summary":"Jefferies initiates coverage of SoFi shares with a bullish rating\nSoFi Technologies Inc.'s strong pr","content":"<p>Jefferies initiates coverage of SoFi shares with a bullish rating</p>\n<p><a href=\"https://laohu8.com/S/SOFI\">SoFi Technologies Inc.</a>'s strong product portfolio could help lift its shares roughly 50% higher, according to one analyst's model--and that's on top of a 10% rally Wednesday.</p>\n<p>Shares of SoFi (SOFI) surged Wednesday after Jefferies analyst John Hecht chimed in with an upbeat view of the digital-finance stock, setting a buy rating and $25 target price. That price target might end up being conservative, Hecht said, since his model accounts for each of SoFi's products individually and doesn't factor in the powerful \"flywheel\" effect he thinks the company can leverage through its ample opportunity to cross-sell products.</p>\n<p>\"Rather than directly pursuing member growth with large dollar loans, SoFi eases consumers into the ecosystem by giving them free access to high-frequency products and lower costs,\" Hecht wrote. \"Following that, SoFi's simple [user interface/user experience] draws customers toward ancillary products.\"</p>\n<p>The ability to sell existing customers on new products bodes well for SoFi's margins, according to Hecht, who predicts that SoFi will reach profitability on a GAAP basis within the next three years. He expects that the company will be able to lower costs through the benefits of scale, allowing it to pass on savings to customers in order to generate more engagement with the platform.</p>\n<p>\"This cycle self-reinforces and drives more growth,\" he wrote.</p>\n<p>Hecht is also optimistic about the company's banking ambitions after earlier this year it announced plans to acquire a small community bank to help speed up its process of getting a banking charter.</p>\n<p>\"This enhances the value proposition for SoFi members while driving down costs compared to the current process of financing loan offerings in a nonbank,\" he wrote. \"Ultimately, this would allow it to conduct normal banking operations without the legacy bricks-and-mortar infrastructure, in turn creating a cheaper base to make loans to its customers.\"</p>\n<p>Shares of SoFi have fallen 20.8% over the past three months as the S&amp;P 500 has risen 3.5%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>As SoFi stock surges, one analyst sees at least 50% more upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAs SoFi stock surges, one analyst sees at least 50% more upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-09-23 10:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jefferies initiates coverage of SoFi shares with a bullish rating</p>\n<p><a href=\"https://laohu8.com/S/SOFI\">SoFi Technologies Inc.</a>'s strong product portfolio could help lift its shares roughly 50% higher, according to one analyst's model--and that's on top of a 10% rally Wednesday.</p>\n<p>Shares of SoFi (SOFI) surged Wednesday after Jefferies analyst John Hecht chimed in with an upbeat view of the digital-finance stock, setting a buy rating and $25 target price. That price target might end up being conservative, Hecht said, since his model accounts for each of SoFi's products individually and doesn't factor in the powerful \"flywheel\" effect he thinks the company can leverage through its ample opportunity to cross-sell products.</p>\n<p>\"Rather than directly pursuing member growth with large dollar loans, SoFi eases consumers into the ecosystem by giving them free access to high-frequency products and lower costs,\" Hecht wrote. \"Following that, SoFi's simple [user interface/user experience] draws customers toward ancillary products.\"</p>\n<p>The ability to sell existing customers on new products bodes well for SoFi's margins, according to Hecht, who predicts that SoFi will reach profitability on a GAAP basis within the next three years. He expects that the company will be able to lower costs through the benefits of scale, allowing it to pass on savings to customers in order to generate more engagement with the platform.</p>\n<p>\"This cycle self-reinforces and drives more growth,\" he wrote.</p>\n<p>Hecht is also optimistic about the company's banking ambitions after earlier this year it announced plans to acquire a small community bank to help speed up its process of getting a banking charter.</p>\n<p>\"This enhances the value proposition for SoFi members while driving down costs compared to the current process of financing loan offerings in a nonbank,\" he wrote. \"Ultimately, this would allow it to conduct normal banking operations without the legacy bricks-and-mortar infrastructure, in turn creating a cheaper base to make loans to its customers.\"</p>\n<p>Shares of SoFi have fallen 20.8% over the past three months as the S&amp;P 500 has risen 3.5%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SOFI":"SoFi Technologies Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169657704","content_text":"Jefferies initiates coverage of SoFi shares with a bullish rating\nSoFi Technologies Inc.'s strong product portfolio could help lift its shares roughly 50% higher, according to one analyst's model--and that's on top of a 10% rally Wednesday.\nShares of SoFi (SOFI) surged Wednesday after Jefferies analyst John Hecht chimed in with an upbeat view of the digital-finance stock, setting a buy rating and $25 target price. That price target might end up being conservative, Hecht said, since his model accounts for each of SoFi's products individually and doesn't factor in the powerful \"flywheel\" effect he thinks the company can leverage through its ample opportunity to cross-sell products.\n\"Rather than directly pursuing member growth with large dollar loans, SoFi eases consumers into the ecosystem by giving them free access to high-frequency products and lower costs,\" Hecht wrote. \"Following that, SoFi's simple [user interface/user experience] draws customers toward ancillary products.\"\nThe ability to sell existing customers on new products bodes well for SoFi's margins, according to Hecht, who predicts that SoFi will reach profitability on a GAAP basis within the next three years. He expects that the company will be able to lower costs through the benefits of scale, allowing it to pass on savings to customers in order to generate more engagement with the platform.\n\"This cycle self-reinforces and drives more growth,\" he wrote.\nHecht is also optimistic about the company's banking ambitions after earlier this year it announced plans to acquire a small community bank to help speed up its process of getting a banking charter.\n\"This enhances the value proposition for SoFi members while driving down costs compared to the current process of financing loan offerings in a nonbank,\" he wrote. \"Ultimately, this would allow it to conduct normal banking operations without the legacy bricks-and-mortar infrastructure, in turn creating a cheaper base to make loans to its customers.\"\nShares of SoFi have fallen 20.8% over the past three months as the S&P 500 has risen 3.5%.","news_type":1,"symbols_score_info":{"SOFI":0.9}},"isVote":1,"tweetType":1,"viewCount":5283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869653158,"gmtCreate":1632283866674,"gmtModify":1676530743027,"author":{"id":"3583641915640836","authorId":"3583641915640836","name":"BlueHi5","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583641915640836","idStr":"3583641915640836"},"themes":[],"title":"","htmlText":"Post&nbsp;","listText":"Post&nbsp;","text":"Post","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/869653158","repostId":"2169324976","repostType":4,"isVote":1,"tweetType":1,"viewCount":5228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860700814,"gmtCreate":1632206241238,"gmtModify":1676530725247,"author":{"id":"3583641915640836","authorId":"3583641915640836","name":"BlueHi5","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583641915640836","idStr":"3583641915640836"},"themes":[],"title":"","htmlText":"Comment&nbsp;","listText":"Comment&nbsp;","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860700814","repostId":"1164753806","repostType":4,"repost":{"id":"1164753806","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632205806,"share":"https://ttm.financial/m/news/1164753806?lang=en_US&edition=fundamental","pubTime":"2021-09-21 14:30","market":"us","language":"en","title":"UK's Johnson discussed taxation with Amazon's Bezos","url":"https://stock-news.laohu8.com/highlight/detail?id=1164753806","media":"Reuters","summary":"LONDON, Sept 21 (Reuters) - British Prime Minister Boris Johnson discussed the issue of taxation whe","content":"<p>LONDON, Sept 21 (Reuters) - British Prime Minister Boris Johnson discussed the issue of taxation when he met Amazon's&nbsp;founder Jeff Bezos in New York, Downing Street said.</p>\n<p>\"The prime minister raised the issue of taxation, and hoped progress could be [made] in implementing the G7 agreement on tax,\" a Downing Street spokesperson said in a readout of the meeting.</p>\n<p>Bezos pledged on Monday to give away $1 billion in grants this year to focus on efforts around conservation.</p>\n<p>The pledge is a part of his previously announced Bezos Earth Fund, which the Amazon founder started last year to execute his $10 billion commitment to fund scientists, activists and non-profit organizations in the fight against climate change.</p>\n<p>“The prime minister welcomed the Bezos Earth Fund’s commitment, announced tonight, to give $1 billion to protect forests and remove carbon from the air,\" Downing Street said.</p>\n<p>\"The prime minister and Mr Bezos agreed to work together to see what more could be done in the run up to and at COP26.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UK's Johnson discussed taxation with Amazon's Bezos</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUK's Johnson discussed taxation with Amazon's Bezos\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-21 14:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LONDON, Sept 21 (Reuters) - British Prime Minister Boris Johnson discussed the issue of taxation when he met Amazon's&nbsp;founder Jeff Bezos in New York, Downing Street said.</p>\n<p>\"The prime minister raised the issue of taxation, and hoped progress could be [made] in implementing the G7 agreement on tax,\" a Downing Street spokesperson said in a readout of the meeting.</p>\n<p>Bezos pledged on Monday to give away $1 billion in grants this year to focus on efforts around conservation.</p>\n<p>The pledge is a part of his previously announced Bezos Earth Fund, which the Amazon founder started last year to execute his $10 billion commitment to fund scientists, activists and non-profit organizations in the fight against climate change.</p>\n<p>“The prime minister welcomed the Bezos Earth Fund’s commitment, announced tonight, to give $1 billion to protect forests and remove carbon from the air,\" Downing Street said.</p>\n<p>\"The prime minister and Mr Bezos agreed to work together to see what more could be done in the run up to and at COP26.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164753806","content_text":"LONDON, Sept 21 (Reuters) - British Prime Minister Boris Johnson discussed the issue of taxation when he met Amazon's founder Jeff Bezos in New York, Downing Street said.\n\"The prime minister raised the issue of taxation, and hoped progress could be [made] in implementing the G7 agreement on tax,\" a Downing Street spokesperson said in a readout of the meeting.\nBezos pledged on Monday to give away $1 billion in grants this year to focus on efforts around conservation.\nThe pledge is a part of his previously announced Bezos Earth Fund, which the Amazon founder started last year to execute his $10 billion commitment to fund scientists, activists and non-profit organizations in the fight against climate change.\n“The prime minister welcomed the Bezos Earth Fund’s commitment, announced tonight, to give $1 billion to protect forests and remove carbon from the air,\" Downing Street said.\n\"The prime minister and Mr Bezos agreed to work together to see what more could be done in the run up to and at COP26.\"","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":5349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860700383,"gmtCreate":1632206212942,"gmtModify":1676530725271,"author":{"id":"3583641915640836","authorId":"3583641915640836","name":"BlueHi5","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583641915640836","idStr":"3583641915640836"},"themes":[],"title":"","htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860700383","repostId":"1131795060","repostType":4,"isVote":1,"tweetType":1,"viewCount":3881,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860054186,"gmtCreate":1632111164845,"gmtModify":1676530703361,"author":{"id":"3583641915640836","authorId":"3583641915640836","name":"BlueHi5","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583641915640836","idStr":"3583641915640836"},"themes":[],"title":"","htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860054186","repostId":"2168505605","repostType":4,"isVote":1,"tweetType":1,"viewCount":3603,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887148436,"gmtCreate":1632012036925,"gmtModify":1676530685288,"author":{"id":"3583641915640836","authorId":"3583641915640836","name":"BlueHi5","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583641915640836","idStr":"3583641915640836"},"themes":[],"title":"","htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/887148436","repostId":"2168957763","repostType":4,"isVote":1,"tweetType":1,"viewCount":4515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884787545,"gmtCreate":1631934265587,"gmtModify":1676530673355,"author":{"id":"3583641915640836","authorId":"3583641915640836","name":"BlueHi5","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583641915640836","idStr":"3583641915640836"},"themes":[],"title":"","htmlText":"Comment&nbsp;","listText":"Comment&nbsp;","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/884787545","repostId":"2168716185","repostType":4,"isVote":1,"tweetType":1,"viewCount":5482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885688470,"gmtCreate":1631785747690,"gmtModify":1676530635356,"author":{"id":"3583641915640836","authorId":"3583641915640836","name":"BlueHi5","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583641915640836","idStr":"3583641915640836"},"themes":[],"title":"","htmlText":"Comment&nbsp;","listText":"Comment&nbsp;","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/885688470","repostId":"1195990706","repostType":4,"repost":{"id":"1195990706","kind":"news","pubTimestamp":1631781148,"share":"https://ttm.financial/m/news/1195990706?lang=en_US&edition=fundamental","pubTime":"2021-09-16 16:32","market":"us","language":"en","title":"3 COVID Stocks That Might Double Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=1195990706","media":"Motley Fool","summary":"Here are three healthcare stocks as nominees for a quick double in 2021.","content":"<p>Anything can happen in the short term, so it's folly to say that a stock is a sure thing for a quick double. Nonetheless, these Fool.com contributors are bullish on these three healthcare stocks, and there are reasons for short-term optimism.</p>\n<p>Read more to find out why we think&nbsp;<b>Novavax</b>(NASDAQ:NVAX),&nbsp;<b>Sorrento Therapeutics</b>(NASDAQ:SRNE), and&nbsp;<b>InMode</b>(NASDAQ:INMD)will close out 2021 with a bang.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cf7858be2535b72fb5033e8b4d227614\" tg-width=\"2000\" tg-height=\"1125\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>1. Multiple catalysts will make Novavax shares jump in 2021</b></p>\n<p><b>Taylor Carmichael(Novavax):</b>Novavax stock has already doubled this year, running from $112 back in January to $233 this week. But there's plenty of gas left in the tank, and I expect another double by the end of the year.</p>\n<p>Right now,<b>Moderna</b>&nbsp;enjoys a $169 billion market cap, and&nbsp;<b>BioNTech</b>&nbsp;sports a $79 billion valuation. Meanwhile, Novavax is positively cheap with its $17 billion market cap. The difference, of course, is that the mRNA biotechs have both of their COVID-19 vaccines on the market now, while Novavax is still waiting for its first Emergency Use Authorization. But when the government agencies start allowing Novavax to distribute its COVID-19 vaccine, the stock will really start to soar.</p>\n<p>The majority of the world's population still has not been vaccinated. Novavax will have 2 billion doses of vaccine ready to distribute in 2022. And the biotech has multiple agreements for supplying locations around the world: 100 million doses for the U.S., 150 million doses for Japan, 200 million doses for Europe, and over 1 billion doses for the developing world.</p>\n<p>The U.S. paid $1.3 billion in advance to secure its 100 million doses of the company's experimental vaccine. That works out to $13 a dose. While the dollar amounts of the various purchase agreements are undisclosed, Japan and Europe will likely pay a higher dollar amount, while the developing world agreements will be discounted. It's entirely possible that Novavax's revenue next year will be higher than its&nbsp;market cap&nbsp;today.</p>\n<p>I'm expecting Novavax shares to spike higher as its vaccine starts receiving authorization around the world in the fourth quarter. Novavax's vaccine candidate will be popular both as a booster shot and as an initial vaccine for the majority of the world who are unvaccinated. And Novavax is leading in the race to combine the COVID-19 vaccine with a flu vaccine. The company just kicked off a combo trial in Australia involving 640 people who have been vaccinated against both diseases with a single shot.</p>\n<p><b>2. Sorrento Therapeutics: Don't sleep on this name</b></p>\n<p><b>George Budwell(Sorrento Therapeutics):</b>The clinical-stage biotech Sorrento Therapeutics rose to prominence last year thanks to its impressive lineup of experimental COVID-19 diagnostics and biologic therapies. The biotech's stock, in fact, gained a whopping 144% from January 2020 to March 2021 mostly because of its broad spectrum of COVID-19 vaccine candidates. Sorrento's shares, however, have now lost almost a quarter of their value over the past 180 days. Investors have apparently moved on to greener pastures, given the company's inability to bring even one of its various&nbsp;COVID-19 vaccine candidates&nbsp;to market in the United States.</p>\n<p>The core issue is that multiple biopharmas have been successful at developing and subsequently marketing COVID-19 vaccines, tests, and therapeutic antibodies in key markets like the U.S. and European Union over the last few months. Meanwhile, Sorrento is still on the hunt for its first major regulatory win. What's important for potential investors to understand, though, is that the pandemic is far from over. COVID-19 is highly likely to morph into a seasonal respiratory ailment. As such, investors shouldn't necessarily write off latecomers such as Sorrento. Eventually, the company could realize a healthy revenue stream from a COVID-19 diagnostic and/or therapeutic.</p>\n<p>It is entirely possible that Sorrento could garner multiple regulatory approvals for its COVID-19 vaccine candidates in the U.S. within the next calendar year, which would be a major boon for its stock. That said, this mid-cap biotech stock will surely remain on the volatile side until the company lands a Food and Drug Administration approval within the COVID-19 space. Invest accordingly.</p>\n<p><b>3. InMode stock will spike as the world reopens</b></p>\n<p><b>Patrick Bafuma</b>&nbsp;<b>(InMode):</b>As the world opens back up and people feel more comfortable gathering, the aesthetics market is sure to heat up. That's why my pick for a COVID-19 vaccine stock to double is InMode, the self-proclaimed leading global provider of innovative, minimally invasive aesthetic and wellness solutions, with strong brand recognition.</p>\n<p>Using a razor-and-blades model, the company markets a medical device system and associated consumables that provide an energy source for body contouring. Utilized by multiple medical specialists, including plastic surgeons, dermatologists, gynecologists, ENTs, and ophthalmologists, InMode claims its procedures are longer lasting than laser treatment and less invasive than typical body sculpting procedures like liposuction.</p>\n<p>And this $5.2 billion aesthetics company is firing on all cylinders.In the most recent quarter, InMode reported record revenue of $87.3 million, representing an increase of 184% compared to the second quarter of 2020. Total second-quarter sales outside of the U.S. were $30.9 million, more than triple what it reported during the same period last year. This torrid international growth represented 35% of its total revenue compared to 22% of its total revenue in Q2 2020. Currently operating in 68 countries, the company enjoys a massive runway for continued growth.</p>\n<p>As the world slowly returns to normal, consumers are seeking out treatments that they had delayed due to COVID-19. \"Our demand is strong,\" chief medical officer Spero Theodorou noted on the last conference call. \"It's solid all the way into September. Waiting lists ... (are) about a month out.\"</p>\n<p>Theodorou went on to say, \"Over one-third of the new patients coming in have never had (any aesthetics procedure) done before.\" This indicates that InMode has expanded the body contouring market, which had already reached $6.2 billion worldwide in 2020 despite the COVID-19 pandemic. This market is expected to grow at a compound annual growth rate of 7.2% into 2026, so there is plenty of room to run for InMode.</p>\n<p>With many of us either in the house or masked up since March 2020, I expect continued growth for this aesthetics device maker as COVID-19 wanes. Despite InMode already being up over 180% since the start of 2021, the company has a huge runway, and its razor-and-blades business model continues to be an effective positioning strategy. InMode is already profitable with adjusted diluted earnings per share in Q2 coming in at $1.02 compared to $0.24 per diluted share for the same quarter of 2020. InMode looks like it's shaping up to double its share price again.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Might Double Soon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Might Double Soon\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-16 16:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/15/3-covid-stocks-that-might-double-soon/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Anything can happen in the short term, so it's folly to say that a stock is a sure thing for a quick double. Nonetheless, these Fool.com contributors are bullish on these three healthcare stocks, and ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/15/3-covid-stocks-that-might-double-soon/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SRNE":"索伦托医疗","NVAX":"诺瓦瓦克斯医药","INMD":"InMode Ltd."},"source_url":"https://www.fool.com/investing/2021/09/15/3-covid-stocks-that-might-double-soon/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195990706","content_text":"Anything can happen in the short term, so it's folly to say that a stock is a sure thing for a quick double. Nonetheless, these Fool.com contributors are bullish on these three healthcare stocks, and there are reasons for short-term optimism.\nRead more to find out why we think Novavax(NASDAQ:NVAX), Sorrento Therapeutics(NASDAQ:SRNE), and InMode(NASDAQ:INMD)will close out 2021 with a bang.\nIMAGE SOURCE: GETTY IMAGES.\n1. Multiple catalysts will make Novavax shares jump in 2021\nTaylor Carmichael(Novavax):Novavax stock has already doubled this year, running from $112 back in January to $233 this week. But there's plenty of gas left in the tank, and I expect another double by the end of the year.\nRight now,Moderna enjoys a $169 billion market cap, and BioNTech sports a $79 billion valuation. Meanwhile, Novavax is positively cheap with its $17 billion market cap. The difference, of course, is that the mRNA biotechs have both of their COVID-19 vaccines on the market now, while Novavax is still waiting for its first Emergency Use Authorization. But when the government agencies start allowing Novavax to distribute its COVID-19 vaccine, the stock will really start to soar.\nThe majority of the world's population still has not been vaccinated. Novavax will have 2 billion doses of vaccine ready to distribute in 2022. And the biotech has multiple agreements for supplying locations around the world: 100 million doses for the U.S., 150 million doses for Japan, 200 million doses for Europe, and over 1 billion doses for the developing world.\nThe U.S. paid $1.3 billion in advance to secure its 100 million doses of the company's experimental vaccine. That works out to $13 a dose. While the dollar amounts of the various purchase agreements are undisclosed, Japan and Europe will likely pay a higher dollar amount, while the developing world agreements will be discounted. It's entirely possible that Novavax's revenue next year will be higher than its market cap today.\nI'm expecting Novavax shares to spike higher as its vaccine starts receiving authorization around the world in the fourth quarter. Novavax's vaccine candidate will be popular both as a booster shot and as an initial vaccine for the majority of the world who are unvaccinated. And Novavax is leading in the race to combine the COVID-19 vaccine with a flu vaccine. The company just kicked off a combo trial in Australia involving 640 people who have been vaccinated against both diseases with a single shot.\n2. Sorrento Therapeutics: Don't sleep on this name\nGeorge Budwell(Sorrento Therapeutics):The clinical-stage biotech Sorrento Therapeutics rose to prominence last year thanks to its impressive lineup of experimental COVID-19 diagnostics and biologic therapies. The biotech's stock, in fact, gained a whopping 144% from January 2020 to March 2021 mostly because of its broad spectrum of COVID-19 vaccine candidates. Sorrento's shares, however, have now lost almost a quarter of their value over the past 180 days. Investors have apparently moved on to greener pastures, given the company's inability to bring even one of its various COVID-19 vaccine candidates to market in the United States.\nThe core issue is that multiple biopharmas have been successful at developing and subsequently marketing COVID-19 vaccines, tests, and therapeutic antibodies in key markets like the U.S. and European Union over the last few months. Meanwhile, Sorrento is still on the hunt for its first major regulatory win. What's important for potential investors to understand, though, is that the pandemic is far from over. COVID-19 is highly likely to morph into a seasonal respiratory ailment. As such, investors shouldn't necessarily write off latecomers such as Sorrento. Eventually, the company could realize a healthy revenue stream from a COVID-19 diagnostic and/or therapeutic.\nIt is entirely possible that Sorrento could garner multiple regulatory approvals for its COVID-19 vaccine candidates in the U.S. within the next calendar year, which would be a major boon for its stock. That said, this mid-cap biotech stock will surely remain on the volatile side until the company lands a Food and Drug Administration approval within the COVID-19 space. Invest accordingly.\n3. InMode stock will spike as the world reopens\nPatrick Bafuma (InMode):As the world opens back up and people feel more comfortable gathering, the aesthetics market is sure to heat up. That's why my pick for a COVID-19 vaccine stock to double is InMode, the self-proclaimed leading global provider of innovative, minimally invasive aesthetic and wellness solutions, with strong brand recognition.\nUsing a razor-and-blades model, the company markets a medical device system and associated consumables that provide an energy source for body contouring. Utilized by multiple medical specialists, including plastic surgeons, dermatologists, gynecologists, ENTs, and ophthalmologists, InMode claims its procedures are longer lasting than laser treatment and less invasive than typical body sculpting procedures like liposuction.\nAnd this $5.2 billion aesthetics company is firing on all cylinders.In the most recent quarter, InMode reported record revenue of $87.3 million, representing an increase of 184% compared to the second quarter of 2020. Total second-quarter sales outside of the U.S. were $30.9 million, more than triple what it reported during the same period last year. This torrid international growth represented 35% of its total revenue compared to 22% of its total revenue in Q2 2020. Currently operating in 68 countries, the company enjoys a massive runway for continued growth.\nAs the world slowly returns to normal, consumers are seeking out treatments that they had delayed due to COVID-19. \"Our demand is strong,\" chief medical officer Spero Theodorou noted on the last conference call. \"It's solid all the way into September. Waiting lists ... (are) about a month out.\"\nTheodorou went on to say, \"Over one-third of the new patients coming in have never had (any aesthetics procedure) done before.\" This indicates that InMode has expanded the body contouring market, which had already reached $6.2 billion worldwide in 2020 despite the COVID-19 pandemic. This market is expected to grow at a compound annual growth rate of 7.2% into 2026, so there is plenty of room to run for InMode.\nWith many of us either in the house or masked up since March 2020, I expect continued growth for this aesthetics device maker as COVID-19 wanes. Despite InMode already being up over 180% since the start of 2021, the company has a huge runway, and its razor-and-blades business model continues to be an effective positioning strategy. InMode is already profitable with adjusted diluted earnings per share in Q2 coming in at $1.02 compared to $0.24 per diluted share for the same quarter of 2020. InMode looks like it's shaping up to double its share price again.","news_type":1,"symbols_score_info":{"NVAX":0.9,"SRNE":0.9,"INMD":0.9}},"isVote":1,"tweetType":1,"viewCount":4822,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882819397,"gmtCreate":1631672836219,"gmtModify":1676530605606,"author":{"id":"3583641915640836","authorId":"3583641915640836","name":"BlueHi5","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583641915640836","idStr":"3583641915640836"},"themes":[],"title":"","htmlText":"Comment&nbsp;","listText":"Comment&nbsp;","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/882819397","repostId":"1128771090","repostType":4,"repost":{"id":"1128771090","kind":"news","pubTimestamp":1631671773,"share":"https://ttm.financial/m/news/1128771090?lang=en_US&edition=fundamental","pubTime":"2021-09-15 10:09","market":"us","language":"en","title":"Cathie Wood Continues To Trim Tesla Stake, Selling Another $66M Worth Of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1128771090","media":"Benzinga","summary":"Cathie Wood-led Ark Invest on Tuesday further lowered some of its exposure in Tesla Inc (Get Free Al","content":"<div>\n<p>Cathie Wood-led Ark Invest on Tuesday further lowered some of its exposure in Tesla Inc (Get Free Alerts for TSLA), booking profits in the stock as it showed some signs of recovery in the recent days ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/09/22943830/cathie-wood-continues-to-trim-tesla-stake-selling-another-66m-worth-of-shares\">Source Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Continues To Trim Tesla Stake, Selling Another $66M Worth Of Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Continues To Trim Tesla Stake, Selling Another $66M Worth Of Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-15 10:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/09/22943830/cathie-wood-continues-to-trim-tesla-stake-selling-another-66m-worth-of-shares><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood-led Ark Invest on Tuesday further lowered some of its exposure in Tesla Inc (Get Free Alerts for TSLA), booking profits in the stock as it showed some signs of recovery in the recent days ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/09/22943830/cathie-wood-continues-to-trim-tesla-stake-selling-another-66m-worth-of-shares\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.benzinga.com/news/21/09/22943830/cathie-wood-continues-to-trim-tesla-stake-selling-another-66m-worth-of-shares","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128771090","content_text":"Cathie Wood-led Ark Invest on Tuesday further lowered some of its exposure in Tesla Inc (Get Free Alerts for TSLA), booking profits in the stock as it showed some signs of recovery in the recent days after months of dull performance.\nThe popular asset management firm sold 88,924 shares — estimated to be worth $66.2 million — in the Elon Musk-led company on Tuesday, its third such trade in Tesla in September.\nWith the latest sales, Ark Invest has trimmed a total of 272,572 shares — estimated to be worth about $200 million — in the Palo Alto, California-based company so far this month.\nTesla shares, which have risen about 1.5% since last week, closed 0.20% higher at $744.49 a share on Tuesday. On a YTD basis, Tesla shares have risen about 2%.\nArk Invest deployed the Ark Next Generation Internet ETF and the Ark Innovation ETF to sell shares in Tesla. Ark Invest also owns shares in Tesla via the Ark Autonomous Technology & Robotics ETF(BATS:ARKQ).\nWood’s firm holds large bets in Tesla, which it predicts will hit the$3,000 mark at the end of 2025.\nEach of the three ETFs count Tesla as their largest exposure and held a total of 4.3 million shares — worth $3.19 billion — in the electric vehicle company, ahead of Tuesday’s trades. No other Ark ETF owns shares in Tesla.\nHere are some of the other key trades for Ark on Tuesday:\n\nBought 235,600 shares in Zoom Video Communications Inc.\nBought 236,373 shares in Robinhood Markets Inc.\nSold 30,905 shares in Iridium Communications Inc.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":4781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886898536,"gmtCreate":1631578742825,"gmtModify":1676530579106,"author":{"id":"3583641915640836","authorId":"3583641915640836","name":"BlueHi5","avatar":"https://static.tigerbbs.com/671977f31bd2446b8dbd85361aab6883","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583641915640836","idStr":"3583641915640836"},"themes":[],"title":"","htmlText":"Liked","listText":"Liked","text":"Liked","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/886898536","repostId":"2167692535","repostType":4,"isVote":1,"tweetType":1,"viewCount":4829,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":true}